The 23rd EHA Congress brought many advances in the biology and treatment of lymphoid malignancies and plasma cell disorders. A vast area was covered, from elucidating the mechanisms underlying oncogenic transformation to practice-changing clinical research.
3D genome dynamics in normal and neoplastic B cells
Epigenetic control of the germinal center reaction and lymphomagenesis
Liquid biopsy in lymphoma